Walaa Elnaiem
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Walaa Elnaiem has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
- Elfatih Ahmed Hasabo
Royal College of Surgeons in Ireland (RCSI) University of Medicine and Health Sciences, Dublin, Ireland
3 shared publications - Lina Hemmeda
Faculty of Medicine, University of Khartoum, Khartoum, Sudan
3 shared publications - Alaa S. Ahmed
Faculty of Medicine, University of Khartoum, Khartoum, Sudan
2 shared publications - Ammar Elgadi
Faculty of Medicine, University of Khartoum, Khartoum, Sudan
2 shared publications - Khabab Abbasher Hussien Mohamed Ahmed
Faculty of Medicine University of Khartoum Khartoum Sudan
2 shared publications - Mohammed Mahmmoud Fadelallah Eljack
University of Bakhtalruda, Faculty of Medicine and Health Sciences Ad Douiem Sudan
2 shared publications
Latest Publications
- Open Access
- 27 February 2026
- Published by Elsevier in International Journal of Cardiology Cardiovascular Risk and Prevention
- Vol. 29, 200610
Left ventricular systolic recovery after TAVI in severe aortic stenosis: A systematic review and meta-analysis
- 27 February 2026
- Published by Elsevier in International Journal of Cardiology Cardiovascular Risk and Prevention
- Vol. 29, 200610
Open AccessLeft ventricular systolic recovery after TAVI in severe aortic stenosis: A systematic review and meta-analysis
- Open Access
- 17 September 2025
- Published by Elsevier in Travel Medicine and Infectious Disease
- Vol. 68, 102908
Intermittent preventive treatment regimens for malaria in HIV-positive pregnant women: Systematic review and meta-analysis of clinical trials
- 17 September 2025
- Published by Elsevier in Travel Medicine and Infectious Disease
- Vol. 68, 102908
Open AccessIntermittent preventive treatment regimens for malaria in HIV-positive pregnant women: Systematic review and meta-analysis of clinical trials
- Open Access
- 17 October 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85 (12) , 5908-5918
Fear of a new pandemic: perception and prediction of monkeypox among the middle east general population
Background: Monkeypox is a zoonotic disease caused by the monkeypox virus, an Orthopox virus. The 2022 monkeypox outbreak provoked fear among the public. Public awareness about the disease could be an important factor in its control. The authors conducted this study to assess the perception and prediction of monkeypox among the Middle East public. Methods: This cross-sectional study was conducted in August 2022. Data were conveniently collected from eight Middle Eastern countries using an online self-administered questionnaire distributed through educational and social media platforms. Statistical analysis was conducted using R software. Results: Approximately 11 016 individuals participated in this study. The participants’ overall knowledge score indicated poor knowledge about monkeypox. Most of the participants knew the causative organism (66.7%). However, numerous participants were not aware of the disease mode of transmission, symptoms, complications, and vaccination. Participants’ awareness was mostly gained from social media (61.8%). The majority predicted acquiring monkeypox when protective measures are not taken (72.7%), progression to a pandemic with economic consequences (50.8 and 52%, respectively), and the ability of the Ministry of Health to control the epidemic (51.5%). Conclusion: In the Middle East, public knowledge about monkeypox is poor. Raising awareness about monkeypox would be of benefit in controlling the epidemic. This study constitutes evidence upon which health education programs could be designed.
- 17 October 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85 (12) , 5908-5918
Open AccessFear of a new pandemic: perception and prediction of monkeypox among the middle east general population
Background: Monkeypox is a zoonotic disease caused by the monkeypox virus, an Orthopox virus. The 2022 monkeypox outbreak provoked fear among the public. Public awareness about the disease could be an important factor in its control. The authors conducted this study to assess the perception and prediction of monkeypox among the Middle East public. Methods: This cross-sectional study was conducted in August 2022. Data were conveniently collected from eight Middle Eastern countries using an online self-administered questionnaire distributed through educational and social media platforms. Statistical analysis was conducted using R software. Results: Approximately 11 016 individuals participated in this study. The participants’ overall knowledge score indicated poor knowledge about monkeypox. Most of the participants knew the causative organism (66.7%). However, numerous participants were not aware of the disease mode of transmission, symptoms, complications, and vaccination. Participants’ awareness was mostly gained from social media (61.8%). The majority predicted acquiring monkeypox when protective measures are not taken (72.7%), progression to a pandemic with economic consequences (50.8 and 52%, respectively), and the ability of the Ministry of Health to control the epidemic (51.5%). Conclusion: In the Middle East, public knowledge about monkeypox is poor. Raising awareness about monkeypox would be of benefit in controlling the epidemic. This study constitutes evidence upon which health education programs could be designed.
- Open Access
- 3 May 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85 (6) , 2865-2874
Efficacy and safety of inhaled nitric oxide administered during cardiopulmonary bypass for pediatric cardiac surgery: a systematic review and meta-analysis
Background and aims: Cardiopulmonary bypass (CPB) utilized for cardiac surgeries has been associated with significant mortality and adverse outcomes. The benefits of incorporating nitric oxide (NO) into the CPB circuit have been reported in terms of reduced inflammation, enhanced dynamic circulation, oxygenation, and end-organ function. This systematic review and meta-analysis aimed to evaluate the efficacy and safety of inhaled NO introduced to the CPB circuit among pediatric patients undergoing various cardiac surgeries. Methods: A systematic literature search was conducted on 26 July 2022, using the electronic databases of PubMed, Cochrane, Scopus, and Web of Science to include randomized controlled trials, with no restriction regarding the date of study conduction. The quality of studies was assessed using the Cochrane tool. RevMan 5.3 software was used to analyze data in the inverse variance method, with pooling data as mean difference (MD), risk ratio, and 95% CI. Results: Six trials were included comprising 1666 children who had undergone the interventions of interest. All studies amenable to assessment were of good quality. NO was significantly superior to the control treatments regarding ventilation time (MD=−8.34; 95% CI [−14.50 to −2.17], P=0.008), postoperative interleukin-6 (IL-6) levels (MD=−0.50; 95% CI [−0.54 to −0.46], PPP=0.05). The side effects of NO and the control treatments were comparable (P=0.9). Conclusion: NO administered as part of the CPB circuit during cardiac surgeries is efficacious in terms of reducing ventilation time, postoperative IL-6, and TNF-α levels compared to control, with a comparable safety profile.
- 3 May 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85 (6) , 2865-2874
Open AccessEfficacy and safety of inhaled nitric oxide administered during cardiopulmonary bypass for pediatric cardiac surgery: a systematic review and meta-analysis
Background and aims: Cardiopulmonary bypass (CPB) utilized for cardiac surgeries has been associated with significant mortality and adverse outcomes. The benefits of incorporating nitric oxide (NO) into the CPB circuit have been reported in terms of reduced inflammation, enhanced dynamic circulation, oxygenation, and end-organ function. This systematic review and meta-analysis aimed to evaluate the efficacy and safety of inhaled NO introduced to the CPB circuit among pediatric patients undergoing various cardiac surgeries. Methods: A systematic literature search was conducted on 26 July 2022, using the electronic databases of PubMed, Cochrane, Scopus, and Web of Science to include randomized controlled trials, with no restriction regarding the date of study conduction. The quality of studies was assessed using the Cochrane tool. RevMan 5.3 software was used to analyze data in the inverse variance method, with pooling data as mean difference (MD), risk ratio, and 95% CI. Results: Six trials were included comprising 1666 children who had undergone the interventions of interest. All studies amenable to assessment were of good quality. NO was significantly superior to the control treatments regarding ventilation time (MD=−8.34; 95% CI [−14.50 to −2.17], P=0.008), postoperative interleukin-6 (IL-6) levels (MD=−0.50; 95% CI [−0.54 to −0.46], PPP=0.05). The side effects of NO and the control treatments were comparable (P=0.9). Conclusion: NO administered as part of the CPB circuit during cardiac surgeries is efficacious in terms of reducing ventilation time, postoperative IL-6, and TNF-α levels compared to control, with a comparable safety profile.
- Open Access
- 13 November 2022
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 84, 104874
Knowledge, attitude and practice of medical students towards COVID19 in Sudan: A cross sectional study among 19 universities
Since December 2019, an outbreak of severe respiratory infection (COVID-19) emerged in the city of Wuhan in China. The knowledge, awareness and practice of medical students toward COVID-19 pandemic is of most importance as it demonstrates their preparedness to deal with this pandemic. The objective of this study is to assess the knowledge, awareness and practice of medical students in Sudan universities about COVID 19. This is a cross-sectional study conducted on 19 universities that have medical schools in Sudan. Data from at least 100 medical students from each university were included in the study. Data were collected using an online questionnaire in April 2020. Statistical analysis was conducted using the Statistical Package for Social Science software, version 25. About 2603 medical students from 19 universities were included. Overall good knowledge and practice were demonstrated by the medical students (88.9%) and (78.6%), respectively. Respondents who answered that the most common clinical symptoms of COVID-19 were the main combination of dry cough, fatigue and fever were (27.7%), and the first initial symptom was headache were (48.3%.). (60.2%) Wear medical masks, (95%) said that avoiding crowded places protects against the spread of COVID-19, and (50.7%) have confidence that Sudan can win the battle against the COVID-19. Finally, (68.8%) agreed that COVID-19 will finally be successfully controlled. This study has found that medical students in Sudan demonstrated good knowledge and good practice toward Covid19.
- 13 November 2022
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 84, 104874
Open AccessKnowledge, attitude and practice of medical students towards COVID19 in Sudan: A cross sectional study among 19 universities
Since December 2019, an outbreak of severe respiratory infection (COVID-19) emerged in the city of Wuhan in China. The knowledge, awareness and practice of medical students toward COVID-19 pandemic is of most importance as it demonstrates their preparedness to deal with this pandemic. The objective of this study is to assess the knowledge, awareness and practice of medical students in Sudan universities about COVID 19. This is a cross-sectional study conducted on 19 universities that have medical schools in Sudan. Data from at least 100 medical students from each university were included in the study. Data were collected using an online questionnaire in April 2020. Statistical analysis was conducted using the Statistical Package for Social Science software, version 25. About 2603 medical students from 19 universities were included. Overall good knowledge and practice were demonstrated by the medical students (88.9%) and (78.6%), respectively. Respondents who answered that the most common clinical symptoms of COVID-19 were the main combination of dry cough, fatigue and fever were (27.7%), and the first initial symptom was headache were (48.3%.). (60.2%) Wear medical masks, (95%) said that avoiding crowded places protects against the spread of COVID-19, and (50.7%) have confidence that Sudan can win the battle against the COVID-19. Finally, (68.8%) agreed that COVID-19 will finally be successfully controlled. This study has found that medical students in Sudan demonstrated good knowledge and good practice toward Covid19.
- Open Access
- 10 July 2022
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 80, 104163
Unilateral accessory brachial artery: A case report with embryological background and review of the literature
Introduction: The accessory brachial artery is a rare arterial variation of the upper limb. It was observed in 0.1-0.8% of upper extremities. In comparison with the brachial artery, the accessory brachial artery has a narrow caliber. Case presentation: During dissection of an old African male cadaver, the brachial artery was observed bifurcating into accessory brachial artery medially and main brachial artery laterally. These two arteries then rejoined in the cubital fossa, forming a common stem, which bifurcated directly into radial and ulnar arteries. Clinical discussion: Detailed knowledge about such arterial variation is clinically essential for angiographic images evaluation, trans-ulnar or trans-radial coronary catheterization, venipuncture, traumatic injuries and fracture management, and many other procedures in the arm or the forearm. Conclusion: The accessory brachial artery is a rare upper limb arterial variation. Knowing such variation is essential for medical workers, especially for surgeons and radiologists.
- 10 July 2022
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 80, 104163
Open AccessUnilateral accessory brachial artery: A case report with embryological background and review of the literature
Introduction: The accessory brachial artery is a rare arterial variation of the upper limb. It was observed in 0.1-0.8% of upper extremities. In comparison with the brachial artery, the accessory brachial artery has a narrow caliber. Case presentation: During dissection of an old African male cadaver, the brachial artery was observed bifurcating into accessory brachial artery medially and main brachial artery laterally. These two arteries then rejoined in the cubital fossa, forming a common stem, which bifurcated directly into radial and ulnar arteries. Clinical discussion: Detailed knowledge about such arterial variation is clinically essential for angiographic images evaluation, trans-ulnar or trans-radial coronary catheterization, venipuncture, traumatic injuries and fracture management, and many other procedures in the arm or the forearm. Conclusion: The accessory brachial artery is a rare upper limb arterial variation. Knowing such variation is essential for medical workers, especially for surgeons and radiologists.
- 21 March 2022
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 37 (5) , e2841
Evaluation of memantine's efficacy and safety in the treatment of children with autism spectrum disorder: A systematic review and meta‐analysis
Background: The United States Food and Drug Administration has approved drugs that address only autism‐related symptoms rather than the underlying impairments. N‐Methyl‐D‐Aspartate receptor antagonists have recently emerged as a promising treatment option for a variety of neurologic and developmental problems, including autism.Aims: To review (systematically), for the first time, the medical literature that explores the safety in and efficacy of memantine in autism.Methods and procedures: A comprehensive electronic search for relevant randomized controlled trials was conducted in four databases. Using RevMan software, we extracted and pooled data as a risk ratio (RR) or normalized mean differences in an inverse variance strategy.Results: This systematic review and meta‐analysis includes five trials. There was no difference in enhancing social responsiveness when compared to placebo, though memantine lowered the likelihood of anxiety (RR = 0.25; 95% Confidence interval: [0.07; 0.87], p = 0.03). However, memantine aggravated impulsive behaviors. Additionally, in another trial that compared memantine added to risperidone versus risperidone added to placebo, memantine was found to be effective and safe.Conclusion: Memantine showed safety in reducing acute symptoms of anxiety and other symptoms encountered in pediatric patients with autism spectrum disorders. However, memantine does not improve the core symptoms of autism. Nevertheless, further long‐term trials are needed to explore its potential efficacy.
- 21 March 2022
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 37 (5) , e2841
Evaluation of memantine's efficacy and safety in the treatment of children with autism spectrum disorder: A systematic review and meta‐analysis
Background: The United States Food and Drug Administration has approved drugs that address only autism‐related symptoms rather than the underlying impairments. N‐Methyl‐D‐Aspartate receptor antagonists have recently emerged as a promising treatment option for a variety of neurologic and developmental problems, including autism.Aims: To review (systematically), for the first time, the medical literature that explores the safety in and efficacy of memantine in autism.Methods and procedures: A comprehensive electronic search for relevant randomized controlled trials was conducted in four databases. Using RevMan software, we extracted and pooled data as a risk ratio (RR) or normalized mean differences in an inverse variance strategy.Results: This systematic review and meta‐analysis includes five trials. There was no difference in enhancing social responsiveness when compared to placebo, though memantine lowered the likelihood of anxiety (RR = 0.25; 95% Confidence interval: [0.07; 0.87], p = 0.03). However, memantine aggravated impulsive behaviors. Additionally, in another trial that compared memantine added to risperidone versus risperidone added to placebo, memantine was found to be effective and safe.Conclusion: Memantine showed safety in reducing acute symptoms of anxiety and other symptoms encountered in pediatric patients with autism spectrum disorders. However, memantine does not improve the core symptoms of autism. Nevertheless, further long‐term trials are needed to explore its potential efficacy.